Evidence map›Paper›PMID 40710723›Full record

ArticleGels (Basel, Switzerland)2025

Tumor Organoids Grown in Mixed-Composition Hydrogels Recapitulate the Plasticity of Pancreatic Cancers.

Ioritz Sorzabal-Bellido, Xabier Morales, Iván Cortés-Domínguez, Maider Esparza, Lucía Grande, Pedro Castillo, Silvia Larumbe, María Monteserín, Shruthi Narayanan, Mariano Ponz-Sarvise and 2 more

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ioritz Sorzabal-BellidoProgram in Biomedical Engineering, CIMA Universidad de Navarra and Cancer Center Clínica Universidad de Navarra (CCUN), 31008 Pamplona, Spain.
Xabier MoralesImaging Platform, CIMA Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-0303-9958
Iván Cortés-DomínguezProgram in Biomedical Engineering, CIMA Universidad de Navarra and Cancer Center Clínica Universidad de Navarra (CCUN), 31008 Pamplona, Spain.ORCID 0000-0001-5660-7694
Maider EsparzaImaging Platform, CIMA Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-7958-3154
Lucía GrandeImaging Platform, CIMA Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-7922-8731
Pedro CastilloProgram in Biomedical Engineering, CIMA Universidad de Navarra and Cancer Center Clínica Universidad de Navarra (CCUN), 31008 Pamplona, Spain.ORCID 0009-0005-5311-1809
Silvia LarumbeCentre for Surface Engineering and Advanced Materials, Asociación de la Industria Navarra (AIN), 31191 Cordovilla, Spain.
María MonteserínCentre for Surface Engineering and Advanced Materials, Asociación de la Industria Navarra (AIN), 31191 Cordovilla, Spain.
Shruthi NarayananProgram in Solid Tumors, CIMA Universidad de Navarra and Cancer Center Clínica Universidad de Navarra (CCUN), 31008 Pamplona, Spain.
Mariano Ponz-SarviseNavarra Health Institute (IDISNA), 31008 Pamplona, Spain.ORCID 0000-0002-3240-729X
Silve VicentNavarra Health Institute (IDISNA), 31008 Pamplona, Spain.ORCID 0000-0002-9457-6881
Carlos Ortiz-de-SolórzanoProgram in Biomedical Engineering, CIMA Universidad de Navarra and Cancer Center Clínica Universidad de Navarra (CCUN), 31008 Pamplona, Spain.ORCID 0000-0001-8720-0205

Funding

Ministry of Science, Innovation and Universities of Spain (MICIU/AEI/10.13039/501100011033) and FEDER, UE A way to make Euro PID2021-122409OB-C22Ministry of Science, Innovation and Universities of Spain (MICIU/AEI/10.13039/501100011033) and FEDER, UE A way to make Europe RTI2018-094494-B-C22
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) tumors exhibit pronounced phenotypic plasticity, alternating between a treatment-sensitive classical phenotype and a more aggressive basal-like state associated with drug resistance and poor prognosis. The frequent coexistence of these phenotypes complicates patient stratification and the selection of effective therapies. Tumor-derived organoids are valuable tools for drug screening; however, their clinical relevance relies on how accurately they recapitulate the phenotypic and functional characteristics of the original tumors. In this study, we present a quantitative analysis of how hydrogel composition influences the phenotype, tissue remodeling, metabolism, and drug resistance of PDAC organoids. Organoids were cultured within three types of hydrogels: Matrigel, collagen-I, and a mixture of collagen-I and Matrigel. Our results demonstrate that: (i) PDAC organoids grown in Matrigel exhibit a classical phenotype, with metabolic and drug response profiles similar to those of low-physiological two-dimensional cultures; (ii) Organoids grown in collagen-containing hydrogels, particularly those in collagen-Matrigel composites, faithfully recapitulate basal-like tumors, characterized by epithelial-to-mesenchymal transition, tissue remodeling, metabolic activity, and drug resistance; (iii) TGFβ induces an exacerbated, highly invasive basal-like phenotype. Summarizing, our findings highlight the importance of 3D hydrogel composition in modulating PDAC organoid phenotype and behavior and suggest collagen-Matrigel hydrogels as the most suitable matrix for modeling PDAC biology.

Indexed as

biomimetic hydrogelsepithelial-to-mesenchymal transition (EMT)extracellular matrix (ECM)mechanobiologymetabolismPDACplasticityremodelingresistancetumor-derived organoids

Identifiers

PMID40710723
PMCPMC12294231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.